Therapeutic Action
Opioid antidiarrhoeal
PDF page 199
Drug reference
Opioid antidiarrhoeal
PDF page 199
Symptomatic treatment of persistent diarrhoea in adults with HIV infection, in combination with rehydration
PDF page 199
Do not exceed indicated doses. Do not administer to children. Do not administer to patients with bloody diarrhoea, ulcerative colitis, diarrhoea due to antibiotics. May cause: constipation, allergic skin reactions, drowsiness, dizziness. In the event of overdosage, treat with naloxone. Pregnancy: no contra-indication Breast-feeding: no contra-indication
PDF page 199
2 mg capsule or tablet
PDF page 199
Adult: 4 mg (2 capsules), then 2 mg (1 capsule) after each loose stool, without exceeding 16 mg daily (8 capsules daily).
PDF page 199
According to clinical response
PDF page 199
Rehydration is essential and must be adapted to the severity of diarrhoea. Loperamide is not included in the WHO list of essential medicines.
PDF page 199
– Below 25 °C
PDF page 200
4 mg (2 capsules), then 2 mg (1 capsule) after each loose stool, without exceeding 16 mg daily (8 capsules daily).
PDF page 199